|
Thalidomide
(marketed as Thalomid) Information
Patient Information
- Patient Information Sheet [HTML] [PDF]
- Frequently Asked Questions and Answers about Thalidomide
[HTML]
Healthcare Professional
Information
Other Information
- FDA Talk Paper
[HTML]
-
Approval Letter [PDF]
-
Thalidomide: Potential Benefits and Risk. An Open Public
Scientific Workshop Sponsored by the National Institutes of Health
and the Food and Drug Administration, September 9-10, 1997, Bethesda,
MD.
-
Executive Summary;
Sep 9, 1997 Transcript;
Sep 10, 1997 Transcript
-
FDA's Medical Review of Thalidomide Clinical Development
-
Forty-Seventh Meeting of the Dermatologic and Opthalmic Drugs
Advisory Committee, Center for Drug Evaluation and Research; Food
and Drug Administration, September 4-5, 1997, Bethesda, MD.;
Sep 4, 1997 Transcript. 271 pages.
Word or
PDF
Sep 5, 1997 Transcript. 211 pages.
Word or
PDF
Supplementary Information Resources
These additional information resources available on
the FDA and National Library of Medicine web sites provide some
useful background information on this topic.
Do Not Buy Thalomid (thalidomide) Over the
Internet
- You should not buy Thalomid (thalidomide) over the Internet
because you will bypass important safeguards designed to protect
your health (and the health of others).
- Thalomid has special safety restrictions on how it is
distributed to the public. Also, drugs
purchased from foreign Internet sources are not the FDA-approved
versions of the drugs, and
they are not subject to FDA-regulated manufacturing controls or
FDA inspection of manufacturing facilities.
To learn more about buying drugs safely, please see
|
Report Adverse Events to
MedWatch
Back
to Top
Back to Drug Info
PDF requires the free Adobe
Acrobat Reader
Date created: March, 2005, updated November 1, 2006 |
|